Related Experiment Video
Updated: May 25, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Cancer genomics: technology, discovery, and translation
Ben Tran1, Janet E Dancey, Suzanne Kamel-Reid
1FRCPC, Princess Margaret Hospital, Drug Development Program, 610 University Ave, Ste 5-718, Toronto, Ontario, M5G 2M9, Canada.
Personalized cancer medicine (PCM) is advancing due to the understanding that genetic mutations drive cancer. Translating cancer genomics into clinical practice involves specific technologies, challenges, and feasibility studies.
Area of Science:
- Oncology
- Genomics
- Translational Medicine
Background:
- Somatic mutations and genetic aberrations are increasingly recognized as drivers of human malignancies.
- This understanding underpins the development of personalized cancer medicine (PCM).
- Key premises for PCM include actionable genetic aberrations and targeted anticancer agents.
Purpose of the Study:
- To highlight the technologies enabling cancer genomics.
- To examine early results and challenges in discovering new genetic aberrations.
- To discuss the translation of cancer genomics into clinical practice.
Main Methods:
- Review of technologies underlying cancer genomics.
- Examination of early genome sequencing results.
- Analysis of a feasibility study on somatic mutation genotyping and targeted exome sequencing.
Main Results:
- Identification of challenges in discovering new genetic aberrations.
- Insights into the processes and issues of translating cancer genomics to the clinic.
- Demonstration of feasibility through a multi-institutional study.
Conclusions:
- Cancer genomics technologies are advancing personalized cancer medicine.
- Translating genomic discoveries into clinical practice presents significant challenges.
- Feasibility studies are crucial for implementing genomic-guided cancer therapies.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

